Navigation Links
BioMS Medical to present at 2008 BIO International Convention
Date:6/12/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, June 12 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the Business Forum at the 2008 BIO International Convention in San Diego, California.

WHEN: Friday June 20th at 10:15 am (PDT)

WHERE: San Diego Convention Center, San Diego

About the 2008 BIO International Convention

The 2008 BIO International Convention, hosted by the Biotechnology Industry Organization, will feature keynotes from industry and global leaders, more than 175 breakout sessions, business partnering meetings, and numerous networking events. The convention also includes more than 200,000 square feet of exhibitions showcasing the latest advancements in biotechnology alongside an array of potential partners, service providers, and state and international delegations. For more information visit http://www.bio2008.org/.

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298 (dirucotide), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to MBP8298 (dirucotide) in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
2. BioMS Medical announces first quarter 2008 results
3. BioMs Medical to present at TIDES(R) Conference
4. BioMS Medical to present at Rodman and Renshaw Global Healthcare Conference
5. BioMS Medical Provides Update On Pipeline Products
6. BioMS Medical announces conference call and web cast for Annual General Meeting
7. BioMS Medical to Participate in Speciality Panel Session at BioFinance 2008
8. BioMS Medical to present at EQUITIES Conference
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. BioMS Medical to present at BioCentury Conference
11. BioMS Medical Announces 2007 Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... NDA with FDA in Early to Mid-2009 , , WOOD... Strativa Pharmaceuticals, the proprietary product...NYSE: PRX ) today announced that its development...letion of all pivotal bioequivalence studies for a...tron thin film product is being developed for the ...
(Date:12/2/2008)...., Dec. 2 GeneGo, Inc., the leadin...hat Burnham has become a certified GeneGo Center o...ution-wide access to GeneGo,s MetaCore data analys...ham institute is a world-class biomedical research...ies throughout many departments, including researc...
(Date:12/2/2008)..., Israel, December 2 InSightec Ltd... Magnetic Resonance-guided Focused,Ultrasound (MR...l to be an,effective noninvasive pain-relieving t... (bone metastases). The results of a 31 patient st...als of Surgical Oncology, while data from an,elev...
(Date:12/2/2008)...OLIS, France, December 2 ...unced it has signed an agreement with,DSM for the...drug substance,(or API, active pharmaceutical ing...nal product and the first compound in the,Cycloox...lass of,anti-inflammatory agents, which recently ...
Breaking Biology Technology:Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
...Roche Discovery Welwyn, 40 Broadwater Road, Welwyn...nt Address: Analytical Sciences, , Syngen...racknell, Berkshire, , RG42 6EY, UK, ...e use of the Bio-Rad PROTEAN Plus Dodeca cell (Fig...ls with preparative protein loads. The Dodeca , ...
... and Carolyn Seggerson 2 , 1 Tech/Aid, , ... 2 Bio-Rad Laboratories, , Inc., 2000 Alf... , Introduction , Running PCR...uming procedure. , It is common to hand c..., A gel of such large size is difficult to...
, , , , back to top
...ction , Amplification of DNA through the...ighly sensitive method capable of copying millions...lecule. 1 Because of the extreme sensitivity of t... previous reactions can result in false positives ...n can be avoided by using positive , disp...
Other Biology Technology:Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 2Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 3Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 4Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A 5Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 2Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 3Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A 4Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 2Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 3
(Date:12/2/2008)...views of nutrition related topics raises unique ch...icine. In a new article, a team of researchers use...s, and limitations of systematic reviews relevant ...he results. , Systematic reviews, also referred...ssessments with pre-specified questions that can b...
(Date:12/1/2008)...- The International Atomic Energy Agency (IAEA) to...eding technique that could bolster efforts aimed a...p. , IAEA scientists use radiation to produce im...imate conditions such as drought or flood, or that...s. Called mutation induction, the technique is saf...
(Date:12/1/2008)...sts around the world may benefit from a powerful n...help them to home in on the parts of proteins most...D, associate professor of pathology and of genetic...ecently launched the novel bioinformatics tool, wh...the role different proteins play in a wide array o...
(Date:12/1/2008)...niversity of Florida, keeper of the world,s shark ...records collection for another toothy marine preda...rum or "saw" that makes it a popular curio item an...orical and cultural icon that is rapidly disappear...urator of both the International Shark Attack File...
Breaking Biology News(10 mins):Experts discuss applying systematic review to the field of nutrition 2Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 1AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 2AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 3AIDS Ignorance 3A One Third of Adults Admit Little or No Knowledge of Pandemic 7197 4Springer launches new journal in musculoskeletal medicine 7194 1Springer launches new journal in musculoskeletal medicine 7194 2FDA Mulls Cutting Salt in Processed Foods 7192 1FDA Mulls Cutting Salt in Processed Foods 7192 2FDA Mulls Cutting Salt in Processed Foods 7192 3FDA Mulls Cutting Salt in Processed Foods 7192 4Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 1Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 2Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 3Exelixis to Receive Milestone Payment From Bristol Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone 7190 4
...sity after the end-Cretaceous mass extinction was ...ng to paleontologists. New fossil evidence shows t...diversity were severely out of balance, not linked... million years ago. Labeled the K-T extinction, it...aleocene Epoch. , "The K-T caused major extinctio...
...volving five major food crops grown under carbon-d...ing dramatically less bounty than those raised in ...ons ?and scientists warn that global food supplies...rategies. , The new findings are based on on-going...t Urbana-Champaign and results gleaned from five o...
...archers have developed a way to synthesize a cance...ity to learn how it works. , Derived from a fungus... cave, the chemical tricks certain cancer cells in..., "In 2000, scientists in Japan discovered that t...as a prototype anticancer agent, but no one has be...
...delivered by a robotic arm eradicated lung tumors ...ment, medical physicist Cihat Ozhasoglu, Ph.D. of ...eport in early August at the 48th Annual Meeting o...ne in Orlando. Although it is too early to determ...oglu and his colleagues find promise in this new a...
Other Biology News:Insect predation sheds light on food web recovery after the dinosaur extinction 2Insect predation sheds light on food web recovery after the dinosaur extinction 3Insect predation sheds light on food web recovery after the dinosaur extinction 4Food-crop yields in future greenhouse-gas conditions lower than expected 2New lab technique churns out fungus' potential cancer fighter 2Radiation-armed robot rapidly destroys human lung tumors 2
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody
...hthoyl-VF-CHO White lyophilized solid. PROTECT F...ble, reversible inhibitor of γ-secretase. Eq...ED 50 = 2.6 μM) and Aβ x-42 (ED 50 = 2....he Amyloid Precursor Protein Swedish mutants. Pur...
Mlu I from New England Biolabs
Corticoliberin
Biology Products: